In the Jan. 11 issue of CMAJ,1 a portion of Dr. Susan Kahn’s competing interests statement was written incorrectly. The statement should have read, with the correction in italics: [Kahn] is a coapplicant and steering committee member on an NIH-funded trial … of pharmacomechanical catheter-directed thrombolysis plus standard anticoagulation versus standard anticoagulation alone to prevent post-thrombotic syndrome after deep venous thrombosis.” CMAJ apologizes for any inconvenience this error may have caused.